Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1002/pbc.22778. Epub 2010 Sep 14.
Affiliations
- PMID: 20842754
- DOI: 10.1002/pbc.22778
Randomized Controlled Trial
Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy
Anu Kochanujan Pillai et al. Pediatr Blood Cancer. 2011 Feb.
Abstract
Purpose: Chemotherapy-induced nausea and vomiting (CINV) are major adverse effects of chemotherapy. Ginger has been used in postoperative and pregnancy-induced nausea and vomiting. Data on its utility in reducing CINV in children and young adults are lacking.
Patients and methods: Sixty chemotherapy cycles of cisplatin/doxorubicin in bone sarcoma patients were randomized to ginger root powder capsules or placebo capsules as an additional antiemetic to ondensetron and dexamethasone in a double-blind design. Acute CINV was defined as nausea and vomiting occurring within 24 hr of start of chemotherapy (days 1-4) and delayed CINV as that occurring after 24 hr of completion of chemotherapy (days 5-10). CINV was evaluated as per Edmonton's Symptom Assessment Scale and National Cancer Institute criteria respectively.
Results: Acute moderate to severe nausea was observed in 28/30 (93.3%) cycles in control group as compared to 15/27 (55.6%) cycles in experimental group (P = 0.003). Acute moderate to severe vomiting was significantly more in the control group compared to the experimental group [23/30 (76.7%) vs. 9/27 (33.33%) respectively (P= 0.002)]. Delayed moderate to severe nausea was observed in 22/30 (73.3%) cycles in the control group as compared to 7/27 (25.9%) in the experimental group (P < 0.001). Delayed moderate to severe vomiting was significantly more in the control group compared to the experimental group [14/30 (46.67%) vs. 4/27 (14.81%) (P = 0.022)].
Conclusion: Ginger root powder was effective in reducing severity of acute and delayed CINV as additional therapy to ondensetron and dexamethasone in patients receiving high emetogenic chemotherapy (ClinicalTrials.gov identifier: NCT00940368).
Copyright © 2010 Wiley-Liss, Inc.
Similar articles
- Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study.
Thamlikitkul L, Srimuninnimit V, Akewanlop C, Ithimakin S, Techawathanawanna S, Korphaisarn K, Chantharasamee J, Danchaivijitr P, Soparattanapaisarn N. Thamlikitkul L, et al. Support Care Cancer. 2017 Feb;25(2):459-464. doi: 10.1007/s00520-016-3423-8. Epub 2016 Oct 6. Support Care Cancer. 2017. PMID: 27714530 Clinical Trial. - Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
Lindley C, Goodin S, McCune J, Kane M, Amamoo MA, Shord S, Pham T, Yowell S, Laliberte K, Schell M, Bernard S, Socinski MA. Lindley C, et al. Am J Clin Oncol. 2005 Jun;28(3):270-6. doi: 10.1097/01.coc.0000145983.35929.2a. Am J Clin Oncol. 2005. PMID: 15923800 Clinical Trial. - A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide.
Tienchaiananda P, Nipondhkit W, Maneenil K, Sa-Nguansai S, Payapwattanawong S, Laohavinij S, Maneechavakajorn J. Tienchaiananda P, et al. Ann Palliat Med. 2019 Sep;8(4):372-380. doi: 10.21037/apm.2019.08.04. Epub 2019 Sep 2. Ann Palliat Med. 2019. PMID: 31500422 Clinical Trial. - Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.
Piechotta V, Adams A, Haque M, Scheckel B, Kreuzberger N, Monsef I, Jordan K, Kuhr K, Skoetz N. Piechotta V, et al. Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD012775. doi: 10.1002/14651858.CD012775.pub2. Cochrane Database Syst Rev. 2021. PMID: 34784425 Free PMC article. Review. - [Efficacy of ondansetron in acute and delayed cisplatin-induced nausea and vomiting].
Depierre A. Depierre A. Bull Cancer. 1996 Feb;83(2):147-53. Bull Cancer. 1996. PMID: 8652909 Review. French.
Cited by
- Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review.
Ben-Arye E, Samuels N, Seifert G, Gressel O, Peleg R, Jong M. Ben-Arye E, et al. Curr Oncol Rep. 2024 Jun;26(6):714-734. doi: 10.1007/s11912-024-01538-1. Epub 2024 May 11. Curr Oncol Rep. 2024. PMID: 38733465 Free PMC article. Review. - Complementary and alternative medicine modalities used to treat adverse effects of anti-cancer treatment among children and young adults: a systematic review and meta-analysis of randomized controlled trials.
Mora DC, Overvåg G, Jong MC, Kristoffersen AE, Stavleu DC, Liu J, Stub T. Mora DC, et al. BMC Complement Med Ther. 2022 Apr 2;22(1):97. doi: 10.1186/s12906-022-03537-w. BMC Complement Med Ther. 2022. PMID: 35366871 Free PMC article. - Bridging cross-cultural gaps: monitoring herbal use during chemotherapy in patients referred to integrative medicine consultation in Israel.
Almog L, Lev E, Schiff E, Linn S, Ben-Arye E. Almog L, et al. Support Care Cancer. 2014 Oct;22(10):2793-804. doi: 10.1007/s00520-014-2261-9. Epub 2014 May 10. Support Care Cancer. 2014. PMID: 24817575 - Cancer cell signaling pathways targeted by spice-derived nutraceuticals.
Sung B, Prasad S, Yadav VR, Aggarwal BB. Sung B, et al. Nutr Cancer. 2012;64(2):173-97. doi: 10.1080/01635581.2012.630551. Epub 2011 Dec 9. Nutr Cancer. 2012. PMID: 22149093 Free PMC article. Review. - Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study.
Thamlikitkul L, Srimuninnimit V, Akewanlop C, Ithimakin S, Techawathanawanna S, Korphaisarn K, Chantharasamee J, Danchaivijitr P, Soparattanapaisarn N. Thamlikitkul L, et al. Support Care Cancer. 2017 Feb;25(2):459-464. doi: 10.1007/s00520-016-3423-8. Epub 2016 Oct 6. Support Care Cancer. 2017. PMID: 27714530 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical